BiondVax
BVXV
$1.36
Share price
0.74%
Change (1 day)
-37.33%
Change (1 year)
Categories
BiondVax (BVXV) - Cash on Hand
Cash on Hand as of June 2023 : $7.5 M
According to BiondVax's latest financial reports the company has $7.5 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BiondVax - Cash on Hand chart (from 2022 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $14.07 M | -19.14% |
| 2021-12-31 | $17.4 M | 1809.13% |
| 2020-12-31 | $0.91 M | -95.65% |
| 2019-12-31 | $20.94 M | 291.17% |
| 2018-12-31 | $5.35 M | -74.19% |
| 2017-12-31 | $20.74 M | 344.92% |
| 2016-12-31 | $4.66 M | -48.79% |
| 2015-12-31 | $9.1 M | 204.82% |
| 2014-12-31 | $2.98 M | -47.8% |
| 2013-12-31 | $5.72 M | 41.15% |
| 2012-12-31 | $4.05 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 2,673.61% | 🇺🇸 USA |